1. Home
  2. OP vs PBM Comparison

OP vs PBM Comparison

Compare OP & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OP
  • PBM
  • Stock Information
  • Founded
  • OP 2021
  • PBM 1994
  • Country
  • OP Greece
  • PBM Canada
  • Employees
  • OP N/A
  • PBM 10
  • Industry
  • OP
  • PBM
  • Sector
  • OP
  • PBM
  • Exchange
  • OP Nasdaq
  • PBM NYSE
  • Market Cap
  • OP 8.5M
  • PBM 5.3M
  • IPO Year
  • OP N/A
  • PBM N/A
  • Fundamental
  • Price
  • OP $1.12
  • PBM $1.37
  • Analyst Decision
  • OP
  • PBM
  • Analyst Count
  • OP 0
  • PBM 0
  • Target Price
  • OP N/A
  • PBM N/A
  • AVG Volume (30 Days)
  • OP 12.1K
  • PBM 526.0K
  • Earning Date
  • OP 12-20-2024
  • PBM 02-02-2025
  • Dividend Yield
  • OP N/A
  • PBM N/A
  • EPS Growth
  • OP N/A
  • PBM N/A
  • EPS
  • OP N/A
  • PBM N/A
  • Revenue
  • OP $25,729,000.00
  • PBM N/A
  • Revenue This Year
  • OP N/A
  • PBM N/A
  • Revenue Next Year
  • OP N/A
  • PBM N/A
  • P/E Ratio
  • OP N/A
  • PBM N/A
  • Revenue Growth
  • OP 36.33
  • PBM N/A
  • 52 Week Low
  • OP $1.02
  • PBM $1.21
  • 52 Week High
  • OP $3.15
  • PBM $323.25
  • Technical
  • Relative Strength Index (RSI)
  • OP 40.22
  • PBM 37.76
  • Support Level
  • OP $1.11
  • PBM $1.21
  • Resistance Level
  • OP $1.24
  • PBM $1.59
  • Average True Range (ATR)
  • OP 0.05
  • PBM 0.24
  • MACD
  • OP -0.00
  • PBM 0.03
  • Stochastic Oscillator
  • OP 7.17
  • PBM 17.53

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary.

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: